Skip to content

Clinical trials

Metabolic Diseases trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Country / region: Mexico Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20081
20092
20102
20141
20151
20161
20181
20201
20223
20232
20248
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting5
Active, not recruiting3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company8
AstraZeneca6
89bio, Inc.3
Alexion Pharmaceuticals, Inc.1
Intellia Therapeutics1
Ionis Pharmaceuticals, Inc.1
Pfizer1
Takeda1
Ultragenyx Pharmaceutical Inc1
Universidad Autonoma de Baja California1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases26
Diabetes Mellitus, Type 215
Glucose Metabolism Disorders14
Endocrine System Diseases13
Diabetes Mellitus12
Hypertriglyceridemia3
Lipid Metabolism Disorders3
Obesity3
Body Weight2
Digestive System Diseases2

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.